326 related articles for article (PubMed ID: 11721890)
1. I1 receptors, cardiovascular function, and metabolism.
Bousquet P
Am J Hypertens; 2001 Nov; 14(11 Pt 2):317S-321S. PubMed ID: 11721890
[TBL] [Abstract][Full Text] [Related]
2. Identification and characterization of I1 imidazoline receptors: their role in blood pressure regulation.
Bousquet P
Am J Hypertens; 2000 Jun; 13(6 Pt 2):84S-88S. PubMed ID: 10921526
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the receptor involved in the central hypotensive effect of rilmenidine and moxonidine.
Bock C; Niederhoffer N; Szabo B
Naunyn Schmiedebergs Arch Pharmacol; 1999 Apr; 359(4):262-71. PubMed ID: 10344524
[TBL] [Abstract][Full Text] [Related]
4. I1-imidazoline receptors: an update.
Bousquet P; Dontenwill M; Greney H; Feldman J
J Hypertens Suppl; 1998 Aug; 16(3):S1-5. PubMed ID: 9747903
[TBL] [Abstract][Full Text] [Related]
5. Does a second generation of centrally acting antihypertensive drugs really exist?
Feldman J; Greney H; Monassier L; Vonthron C; Bruban V; Dontenwill M; Bousquet P
J Auton Nerv Syst; 1998 Oct; 72(2-3):94-7. PubMed ID: 9851557
[TBL] [Abstract][Full Text] [Related]
6. Importance of imidazoline receptors in the cardiovascular actions of centrally acting antihypertensive agents.
Head GA
Ann N Y Acad Sci; 1995 Jul; 763():531-40. PubMed ID: 7677371
[TBL] [Abstract][Full Text] [Related]
7. Site-dependent inhibition of neuronal c-jun in the brainstem elicited by imidazoline I1 receptor activation: role in rilmenidine-evoked hypotension.
Wang X; Li G; Abdel-Rahman AA
Eur J Pharmacol; 2005 May; 514(2-3):191-9. PubMed ID: 15910806
[TBL] [Abstract][Full Text] [Related]
8. Selectivity of rilmenidine for the nucleus reticularis lateralis, a ventrolateral medullary structure containing imidazoline-preferring receptors.
Tibiriça E; Feldman J; Mermet C; Monassier L; Gonon F; Bousquet P
Eur J Pharmacol; 1991 Dec; 209(3):213-21. PubMed ID: 1686768
[TBL] [Abstract][Full Text] [Related]
9. Imidazoline receptors. A new concept in central regulation of the arterial blood pressure.
Bousquet P; Feldman J; Tibirica E; Bricca G; Greney H; Dontenwill M; Stutzmann J; Belcourt A
Am J Hypertens; 1992 Apr; 5(4 Pt 2):47S-50S. PubMed ID: 1350728
[TBL] [Abstract][Full Text] [Related]
10. Why imidazoline receptor modulator in the treatment of hypertension?
Schäfer SG; Kaan EC; Christen MO; Löw-Kröger A; Mest HJ; Molderings GJ
Ann N Y Acad Sci; 1995 Jul; 763():659-72. PubMed ID: 7677385
[TBL] [Abstract][Full Text] [Related]
11. I1 imidazoline receptors in cardiovascular regulation: the place of rilmenidine.
Head GA; Burke SL
Am J Hypertens; 2000 Jun; 13(6 Pt 2):89S-98S. PubMed ID: 10921527
[TBL] [Abstract][Full Text] [Related]
12. Selectivity of rilmenidine for I1-imidazoline-binding sites in rabbit proximal tubule cells.
Gargalidis-Moudanos C; Parini A
J Cardiovasc Pharmacol; 1995; 26 Suppl 2():S59-62. PubMed ID: 8642808
[TBL] [Abstract][Full Text] [Related]
13. A novel mechanism of action for hypertension control: moxonidine as a selective I1-imidazoline agonist.
Ernsberger P; Haxhiu MA; Graff LM; Collins LA; Dreshaj I; Grove DL; Graves ME; Schäfer SG; Christen MO
Cardiovasc Drugs Ther; 1994 Mar; 8 Suppl 1():27-41. PubMed ID: 8068578
[TBL] [Abstract][Full Text] [Related]
14. Central imidazoline- and alpha 2-receptors involved in the cardiovascular actions of centrally acting antihypertensive agents.
Head GA
Ann N Y Acad Sci; 1999 Jun; 881():279-86. PubMed ID: 10415926
[TBL] [Abstract][Full Text] [Related]
15. I1 imidazoline agonists. General clinical pharmacology of imidazoline receptors: implications for the treatment of the elderly.
Prichard BN; Graham BR
Drugs Aging; 2000 Aug; 17(2):133-59. PubMed ID: 10984201
[TBL] [Abstract][Full Text] [Related]
16. Central imidazoline (I1) receptors as targets of centrally acting antihypertensives: moxonidine and rilmenidine.
van Zwieten PA
J Hypertens; 1997 Feb; 15(2):117-25. PubMed ID: 9469786
[TBL] [Abstract][Full Text] [Related]
17. Contribution of imidazoline receptors and alpha2-adrenoceptors in the rostral ventrolateral medulla to sympathetic baroreflex inhibition by systemic rilmenidine.
Chan CK; Burke SL; Head GA
J Hypertens; 2007 Jan; 25(1):147-55. PubMed ID: 17143186
[TBL] [Abstract][Full Text] [Related]
18. Role of I1 imidazoline receptors in the sympathoinhibition produced by intracisternally administered rilmenidine and moxonidine.
Szabo B; Urban R
Arzneimittelforschung; 1997 Sep; 47(9):1009-15. PubMed ID: 9342413
[TBL] [Abstract][Full Text] [Related]
19. Site and receptors involved in the sympathoinhibitory actions of rilmenidine.
Head GA; Burke SL; Chan CK
J Hypertens Suppl; 1998 Aug; 16(3):S7-12. PubMed ID: 9747904
[TBL] [Abstract][Full Text] [Related]
20. No evidence for functional imidazoline receptors on locus coeruleus neurons.
Szabo B; Fröhlich R; Illes P
Naunyn Schmiedebergs Arch Pharmacol; 1996 Apr; 353(5):557-63. PubMed ID: 8740150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
